| Role of phytochemicals in cancer prevention A Ranjan, S Ramachandran, N Gupta, I Kaushik, S Wright, S Srivastava, ... International journal of molecular sciences 20 (20), 4981, 2019 | 359 | 2019 |
| Cancer cells stemness: A doorstep to targeted therapy S Prasad, S Ramachandran, N Gupta, I Kaushik, SK Srivastava Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (4), 165424, 2020 | 128 | 2020 |
| Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy S Gaikwad, MY Agrawal, I Kaushik, S Ramachandran, SK Srivastava Seminars in cancer biology 86, 137-150, 2022 | 122 | 2022 |
| Role of Forkhead Box Class O proteins in cancer progression and metastasis CG Kim, H Lee, N Gupta, S Ramachandran, I Kaushik, S Srivastava, ... Seminars in cancer biology 50, 142-151, 2018 | 101 | 2018 |
| The evolutionary legacy of immune checkpoint inhibitors I Kaushik, S Ramachandran, C Zabel, S Gaikwad, SK Srivastava Seminars in cancer biology 86, 491-498, 2022 | 64 | 2022 |
| Drug rechanneling: A novel paradigm for cancer treatment I Kaushik, S Ramachandran, S Prasad, SK Srivastava Seminars in cancer biology 68, 279-290, 2021 | 56 | 2021 |
| Pimozide suppresses the growth of brain tumors by targeting STAT3-mediated autophagy A Ranjan, I Kaushik, SK Srivastava Cells 9 (9), 2141, 2020 | 37 | 2020 |
| CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment I Kaushik, S Ramachandran, SK Srivastava Seminars in cell & developmental biology 96, 4-12, 2019 | 32 | 2019 |
| Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells N Gupta, S Gaikwad, I Kaushik, SE Wright, MM Markiewski, SK Srivastava International journal of molecular sciences 22 (10), 5150, 2021 | 31 | 2021 |
| Pimavanserin: A novel autophagy modulator for pancreatic cancer treatment S Ramachandran, IS Kaushik, SK Srivastava Cancers 13 (22), 5661, 2021 | 11 | 2021 |
| GABAA receptor agonist suppresses pediatric medulloblastoma progression by inhibiting PKA-Gli1 signaling axis I Kaushik, SK Srivastava Molecular Therapy 30 (7), 2584-2602, 2022 | 8 | 2022 |
| Developing a fully human heavy chain only Claudin-18.2-specific CAR-T cell therapy J Noon, Y Lu, I Kaushik, O Ay, A Luk, B Delaney, D DeMeritt, M Bao Cancer Research 84 (6_Supplement), 6317-6317, 2024 | | 2024 |
| Novel and potent jak/stat inhibitor SK Srivastava, I Kaushik US Patent App. 17/793,434, 2023 | | 2023 |
| Moxidectin unravels the role of Hippo-YAP pathway in maintaining immunity of pediatric glioblastoma I Kaushik, S Gaikwad, SK Srivastava Cancer Research 82 (12_Supplement), 3895-3895, 2022 | | 2022 |
| Abstract LB254: PKA signaling: a friend or foe to pediatric medulloblastoma I Kaushik, S Srivastava Cancer Research 81 (13_Supplement), LB254-LB254, 2021 | | 2021 |
| A novel anthelminthic drug suppresses the growth of medulloblastoma tumors by inhibiting PKA/Gli1 signaling axis I Kaushik, S Srivastava The FASEB Journal 35, 2021 | | 2021 |
| Repurposing neuroleptic drug for brain tumor therapy I Kaushik, S Srivastava The FASEB Journal 33 (S1), 802.80-802.80, 2019 | | 2019 |
| Pimozide suppresses the growth of brain tumor by targeting oncogenic pathways I Kaushik, A Ranjan, B Schwettmann, S Srivastava Cancer Research 78 (13_Supplement), 5452-5452, 2018 | | 2018 |
| A PREVENTIVE APPLICATION IMPROVIZED USING ARID PLANT DERIVATES: NOSOCOMIAL PREVENTIVE REMEDY I KAUSHIK, M DATTA Asian J Pharm Clin Res 9 (2), 150-153, 2016 | | 2016 |
